Skip to main content

Solid Self-Nanoemulsifying Cyclosporine A Pellets Prepared by Fluid-Bed Coating: Stability and Bioavailability Study

Buy Article:

$105.00 plus tax (Refund Policy)

In previous proof-of-concept study, solid cyclosporine A (CsA) loaded self-nanoemulsifying drug delivery system (SNEDDS) pellets were prepared and characterized in vitro with Labrafil M 1944 CS, Cremophor EL and Transcutol P as oil, surfactant and cosurfactants, respectively. In this study, the stability and the oral bioavailability of the solid CsA SNEDDS pellets were evaluated. The solid CsA SNEDDS pellets, either with or without an outer coating with PVP K30, showed strong moisture absorption under relative humidity (RH) of 75% or 92.5%. The content of CsA in both coated and uncoated pellets varied between 98% and 102% after 10 days in stress testing (high temperature: 60 °C or illumination: 4500 lx±500 lx), and between 98% and 104% after two months in accelerated testing (40 °C/75%). However, the redispersibility of uncoated solid SNEDDS pellets decreased in both stress and accelerated testing. The oral bioavailability of the coated solid CsA SNEDDS pellets was (74.89±25.34) % and (81.44±27.96) % that of its liquid counterpart (the liquid CsA SNEDDS) and Neoral® respectively The liquid CsA SNEDDS was bioequivalent to Neoral®. The increased particle size due to the impact of constituents of the pellet core might be the main reason for the reduced oral bioavailability. The in vivo performance of the solid SNEDDS pellets can be further improved. The fluid-bed coating technique has considerable potential for use in the preparation of SNEDDS pellets.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Data/Media
No Metrics


Document Type: Research Article

Publication date: 2012-06-01

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more